Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

v-SNARE Vti1p Activators

Vesicle transport through interaction with t-SNAREs 1B (Vti1b) is a protein that plays a significant role in the vesicular transport system within eukaryotic cells. This system is essential for the trafficking of vesicles, which are small, membrane-enclosed sacs that transport substances between various compartments within the cell, as well as to and from the cell membrane.Vti1b is a member of the SNARE (Soluble NSF Attachment Protein Receptor) family of proteins, which are key components of the machinery that drives the fusion of vesicles with target membranes, a critical step in vesicular transport. t-SNAREs (target membrane SNAREs) like Vti1b are located on target membranes, such as the trans-Golgi network, endosomes, and the plasma membrane, where they interact with v-SNAREs (vesicular SNAREs) on transport vesicles to facilitate membrane fusion.

The Vti1b protein specifically is known to form a complex with other SNARE proteins, a process that brings the vesicle membrane close to the target membrane to initiate fusion. This SNARE complex formation is typically a highly regulated and selective process that ensures vesicles fuse only with the correct target membrane, thus maintaining the directionality and specificity of transport within the cell.Mutations or dysfunctions in Vti1b and other SNARE proteins can lead to disruptions in vesicular transport, which can cause a variety of cellular problems and contribute to the development of diseases, including neurodegenerative disorders and conditions related to impaired cell secretion.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor; might impact cellular pathways requiring UBE2W-mediated ubiquitination.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

Ubiquitin-activating enzyme inhibitor; could alter ubiquitination dynamics involving UBE2W.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modulates ubiquitin ligase activity; potential indirect effects on UBE2W function.

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

NEDD8-activating enzyme inhibitor; may affect cullin-RING ligase activity, influencing UBE2W.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Alters endosomal pH; could influence cellular processes related to UBE2W activity.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Proteasome inhibitor; might stabilize substrates of UBE2W, indirectly affecting its function.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Inhibits N-linked glycosylation, potentially impacting protein stability and UBE2W activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor; could modulate signaling pathways affecting UBE2W.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor; may impact pathways influencing UBE2W-mediated ubiquitination.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Kinase inhibitor; could indirectly influence UBE2W through various signaling pathways.